• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Cemex Posts Q1 Results, Joins Plug Power, Sabre And Other Big Stocks Moving Higher On Monday

    Benzinga·04/28/2025 14:27:13
    Listen to the news

    U.S. stocks were mostly higher, with the Dow Jones index gaining around 200 points on Monday.

    Shares of CEMEX, S.A.B. de C.V. (NYSE:CX) rose sharply during Monday's session following first-quarter results.

    The company reported first-quarter net sales of $3.65 million, missing the consensus of $3.80 billion. Net sales fell 7% year over year (Y/Y), mainly due to lower volumes in Mexico. EBITDA declined 18% Y/Y to $601 million in the quarter, with a margin contracted 2.0ppt Y/Y to 16.5% in the quarter.

    Cemex expects recurrent yearly EBITDA savings of at least $150 million in 2025 and $350 million by 2027.

    Cemex shares jumped 4.2% to $6.16 on Monday.

    Here are some other big stocks recording gains in today's session.

    • Plug Power Inc. (NASDAQ:PLUG) shares jumped 39.4% to $1.13 after the company signed a secured credit facility with Yorkville Advisors. The company also reported preliminary first-quarter results.
    • CG Oncology, Inc. (NASDAQ:CGON) surged 30% to $29.02 after the company announced that cretostimogene grenadenorepvec monotherapy data was presented at the American Urological Association Annual Meeting.
    • Wolfspeed, Inc. (NYSE:WOLF) rose 24.5% to $4.07.
    • Sabre Corporation (NASDAQ:SABR) gained 20.3% to $2.6350 as the company entered into definitive agreement to sell its Hospitality Solutions business unit to TPG for $1.1 billion.
    • Pony AI Inc. (NASDAQ:PONY) rose 17.4% to $8.23.
    • TMC the metals company Inc. (NASDAQ:TMC) gained 15.9% to $3.5350.
    • Rapport Therapeutics, Inc. (NASDAQ:RAPP) climbed 12.6% to $11.96.
    • VEON Ltd. (NASDAQ:VEON) gained 12.2% to $47.83.
    • ADMA Biologics, Inc. (NASDAQ:ADMA) rose 12% to $24.49 as the company announced the FDA approval of its yield enhancement production process.
    • Summit Therapeutics Inc. (NASDAQ:SMMT) gained 10% to $25.79.
    • UroGen Pharma Ltd. (NASDAQ:URGN) gained 10% to $10.85 after the company highlighted nearly four-year duration of response in OLYMPUS long-term follow-up study of JELMYTO.
    • Aurora Innovation, Inc. (NASDAQ:AUR) rose 7.6% to $7.41.
    • Hims & Hers Health, Inc. (NYSE:HIMS) gained 6.1% to $29.82.
    • Peloton Interactive, Inc. (NASDAQ:PTON) rose 5.4% to $6.63. Truist Securities analyst Youssef Squali upgraded Peloton Interactive from Hold to Buy.

    Now Read This:

    Photo via Shutterstock